Cosmic Peptides research library

Health Canada finds bacteria in a peptide seized in Ottawa and says research labels change nothing

On November 12, 2026 Health Canada reported that laboratory testing found the bacterium Sphingomonas aquatilis/melonis in a peptide product seized from an Ottawa wellness business, some of whose vials were labeled for research, and repeated that such labels do not make products legal. What was found, the department's record since 2023, what a peptide certificate does and does not show about bacteria and endotoxin, and what a laboratory can check.

Opinion by Cosmic Peptides. Statements of fact are cited to their sources; the questions and views are ours. This is not legal advice.

Part 5 of 12 · Perspectives

Published · Editorial policy

Health Canada has found bacteria in a peptide product it seized from a wellness business in Ottawa, and says some of the vials it took were labeled for research. Laboratory testing identified Sphingomonas aquatilis/melonis in what the department called an injectable peptide product, it said in a public advisory on November 12, 2026.

The seizure followed a consumer complaint that the business had been selling unauthorized peptides in its store and on its website. Health Canada listed ten unauthorized injectable peptides and one product of oral peptide capsules, from single peptides such as MOTS-c, semax, selank and tesamorelin to multi-peptide blends. The business agreed to stop selling them. The department said it will continue to seize unauthorized peptide products and disrupt distribution channels to remove these products from the Canadian market, working with the Canada Border Services Agency.

Two things make the advisory more than a routine seizure. It reports a measured contamination, not a hypothetical one: a named organism, found by testing, in a product that was being sold. And it restates, in the same document, the department's position that a research label changes nothing in Canadian law. For anyone handling peptides in a laboratory, the finding is also a reminder of what a certificate of analysis usually does not test.

What Health Canada found in the seized peptides

The advisory, number RA-82944, names one organism, Sphingomonas aquatilis/melonis, found in one product. It does not say which of the eleven listed products was contaminated, how many units were tested, or at what level the bacteria were present. It lists the contaminants unauthorized peptides may contain more broadly, including solvents, heavy metals, particles (fibers, glass, plastic), or microbials (bacteria, fungi, endotoxins).

Sphingomonas is a genus of Gram-negative, strictly aerobic, yellow-pigmented bacteria. A 2023 review of the genus in Frontiers in Microbiology records isolates from soils, plant roots, water distribution systems, human samples and hospital machines. Sphingomonas aquatilis was first described in 2001 from strains isolated from natural mineral water. The organism's presence says that the product, or something it touched, was not kept free of an environmental bacterium; it does not by itself say where in manufacture, filling or storage that happened.

Health Canada on the research label, again

The advisory addresses the label directly:

Some of the seized vials were labelled as "For Research Purposes Only," which means the product was manufactured for lab use only, not for human use. These products have not been manufactured or tested to meet the quality standards required for health products for human use. This type of labelling also does not make these products legal or exempt from regulatory requirements.

Health Canada, public advisory RA-82944, November 12, 2026

That is the position the department set out in its April 2026 advisory and has applied since its first action against a research-labeled peptide seller in December 2023. In Canada a drug is defined by what it is sold or represented for, most peptides sold in vials are prescription drugs, and an unauthorized drug may not be sold whatever its label says. Research peptides in Canada sets out the law and the record, which now includes this seizure.

Health Canada's peptide record since 2023

The Ottawa seizure is the latest in a record that runs back three years and has grown steadily more specific. In December 2023 the department ordered an online seller of peptides marketed for research to stop selling unauthorized health products, the first Canadian action of its kind against a research-labeled seller. It seized products from online sellers in June 2024, April 2025 and August 2025, the last with a public list of thirty-eight peptides. In April 2026 it published a general advisory naming fourteen peptides seized or sold online. In June 2026 the Superior Court of Québec granted it a permanent injunction against the seller it had first ordered to stop.

What is new in November is the laboratory result. Earlier advisories warned that unauthorized peptides might be contaminated, under-strength or mislabeled. This one reports that a seized product was tested and that a named bacterium was found in it. The advisory does not say whether the department has tested other seized products or what it found if it did.

What a peptide certificate shows about bacteria, and what it does not

Identity by mass spectrometry and purity by HPLC, the two tests at the core of a peptide certificate, do not detect bacteria. A purity chromatogram measures what absorbs ultraviolet light at 214 to 220 nm; a living contaminant at the levels that matter is invisible to it, and so is its chemistry. What HPLC does not see covers the rest of the vial.

Two different measurements address microbes, and they answer different questions. A test that cultures the sample asks whether living organisms are present. An endotoxin test, by the Limulus amebocyte lysate method or recombinant Factor C, measures the lipopolysaccharide of Gram-negative bacteria, which survives after the bacteria are killed or filtered out. A negative culture does not rule out endotoxin, and a low endotoxin result does not show that a vial is free of living organisms. Endotoxin testing explains the methods and what can make them wrong.

For cell-based work the distinction matters: endotoxin at picogram levels can activate cultured immune and endothelial cells. Does endotoxin matter in the laboratory? sets out why. The conditions in the October 2026 HHS notice for compounding six peptides, as counsel who have read the policy describe them, list microbiological quality and endotoxin on the certificate alongside identity and purity. A certificate that reports only identity and purity says nothing about either.

What a laboratory can check on a peptide certificate

A laboratory that uses peptides in cell-based work can ask three questions of any certificate before the material goes near a culture.

  • Is endotoxin reported? If so, the result should name its method and be expressed in endotoxin units per milligram (EU/mg), against a stated limit. A figure without a method or units cannot be compared with anything.
  • Is a microbial test reported? A culture-based count or test for living organisms answers a different question from endotoxin, and only it addresses the kind of finding in the Ottawa advisory.
  • Is it the same lot? Contamination is a property of a batch and of how it was filled and stored. A certificate for another lot says nothing about the vial on the bench. Does one certificate cover every lot? explains why.

Where the certificate is silent, the laboratory can measure endotoxin itself, on the solution it actually uses, with a Limulus amebocyte lysate or recombinant Factor C assay. Handling then decides whether anything is added after the vial is opened: single-use aliquots, dated and labeled with the lot, are set out in storing peptide solutions.

What the advisory does not establish

The advisory reports one organism in one product from one seller. It does not say the contamination is typical of peptides sold online, in Canada or elsewhere, and it gives no rate. Nor does it say whether the contaminated product was one of those labeled for research. A reader should not take it as evidence about any other product. What it does establish is that a regulator tested a seized peptide for microbes and found them, which is more than most buyers are in a position to do.

What to watch after Health Canada's peptide advisory

  • More testing. Whether Health Canada publishes test results for other seized peptides, and whether other regulators do the same.
  • The border. The department says it is working with the Canada Border Services Agency to stop unauthorized peptide shipments entering Canada.
  • Certificates. Whether research suppliers report microbial limits and endotoxin alongside identity and purity.

Frequently asked questions

What did Health Canada find in the seized peptides?
Laboratory testing found the bacterium Sphingomonas aquatilis/melonis in a peptide product seized from a wellness business in Ottawa, according to public advisory RA-82944 of November 12, 2026.
What is Sphingomonas?
A genus of Gram-negative, aerobic, yellow-pigmented bacteria found in soil, water distribution systems and hospital equipment. Sphingomonas aquatilis was first described from natural mineral water.
Does a "For Research Purposes Only" label make a peptide legal in Canada?
No. Health Canada said in the same advisory that such labelling does not make these products legal or exempt from regulatory requirements.
Does a certificate of analysis show whether a peptide has bacteria in it?
Not unless it reports the right tests. HPLC and mass spectrometry do not detect bacteria. Living organisms are detected by culture, and bacterial endotoxin by a separate endotoxin test. A certificate shows them only if it reports those tests.

Sources & Further Reading

  1. Health Canada. Public advisory: Health Canada warns about unauthorized peptides, including contaminated injectable peptides sold by a wellness business in Ottawa. RA-82944, November 12, 2026, recalls-rappels.canada.ca. The business's name omitted by this library's policy.
  2. Sorouri, Rodriguez, Gaut, et al. Variation in Sphingomonas traits across habitats and phylogenetic clades. Frontiers in Microbiology 2023. doi:10.3389/fmicb.2023.1146165.
  3. Lee et al. Sphingomonas aquatilis sp. nov., Sphingomonas koreensis sp. nov., and Sphingomonas taejonensis sp. nov., yellow-pigmented bacteria isolated from natural mineral water. International Journal of Systematic and Evolutionary Microbiology 2001;51(4):1491. doi:10.1099/00207713-51-4-1491.
  4. Health Canada. Think twice before injecting peptides bought online. Public advisory, April 9, 2026.
  5. Department of Health and Human Services. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances; notice of availability. 91 FR 68526, October 30, 2026.

See also

Cite this page

Text

Cosmic Peptides. (2026, November 16). Health Canada finds bacteria in a peptide seized in Ottawa and says research labels change nothing. Cosmic Peptides Research Library. Retrieved November 16, 2026, from https://cosmicpeptides.com/research/perspectives/health-canada-bacteria-in-seized-peptides

BibTeX

@misc{cosmicpeptides_research_perspectives_health_canada_bacteria_in_seized_peptides,
  author       = {{Cosmic Peptides}},
  title        = {Health Canada finds bacteria in a peptide seized in Ottawa and says research labels change nothing},
  howpublished = {Cosmic Peptides Research Library},
  year         = {2026},
  month        = nov,
  url          = {https://cosmicpeptides.com/research/perspectives/health-canada-bacteria-in-seized-peptides},
  urldate      = {2026-11-16},
  note         = {Last reviewed 2026-11-16}
}

RIS

TY  - ELEC
AU  - Cosmic Peptides
TI  - Health Canada finds bacteria in a peptide seized in Ottawa and says research labels change nothing
T2  - Cosmic Peptides Research Library
PB  - Cosmic Peptides
PY  - 2026
DA  - 2026/11/16
UR  - https://cosmicpeptides.com/research/perspectives/health-canada-bacteria-in-seized-peptides
Y2  - 2026/11/16
LA  - en
ER  - 

Cite the date the page was last reviewed, November 16, 2026, as its version. Reference managers such as Zotero can save this page directly.

Changes to this page

  1. Published Health Canada finds bacteria in a peptide seized in Ottawa and says research labels change nothing

    Opinion: Health Canada advisory RA-82944 of November 12, 2026, Sphingomonas aquatilis/melonis found in a peptide product seized in Ottawa, research-labeled vials among the seizure; the department's record since 2023; what a peptide certificate shows and does not show about bacteria and endotoxin; what a laboratory can check. The Canada page's record and the timeline now include the advisory.

Changes of substance are listed here; wording changes are not. Every correction is also on the corrections log.

For in vitro laboratory research only. Not for human or veterinary use. This library describes chemistry, analytical methods and published laboratory research; it gives no guidance on use in people or animals.